Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 102 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Randomized Phase 2 Dose Comparison LITESPARK-013 Study of Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma
N. Agarwal,J. Brugarolas,P. Ghatalia,S. George,J.B. Haanen,H. Gurney, R. Ravilla,A. Van der Veldt,B. Beuselinck,I. Pokataev,B.B.M. Suelmann, M.H. Tuthill,D. Vaena, F. Zagouri, J. Wu,R.F. Perini, Y. Liu,J. Merchan,M.B. Atkins
Annals of oncology official journal of the European Society for Medical Oncologyno. 12 (2024): 1148-1156
Cited0Views0WOSBibtex
0
0
985 Triple Blockade of DNAM-1axis with COM701(anti-PVRIG)+COM902(anti-TIGIT)+Pembrolizumab Shows Prelim Antitumor Activity in Pts with Platinum Resistant Ovarian Cancer, Interim Results of Phase I Trial
Oladapo Yeku, Manish R Patel, Leigh Seamon,Manish R Sharma, Anne M Noonan, John L Hays,Daniel Vaena, Gady Cojocaro,Inbal Barbiro, Lihi Zimmer-Strulov,Eran Ophir,Pierre Ferre, Michelle Mahler, David O’Malley
Regular and Young Investigator Award Abstracts (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 103

#Citation: 4310

H-Index: 21

G-Index: 63

Sociability: 6

Diversity: 2

Activity: 66

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn